cinacalcet has been researched along with 26,26,26,27,27,27-hexafluoro-1,25-dihydroxyvitamin d3 in 1 studies
| Studies (cinacalcet) | Trials (cinacalcet) | Recent Studies (post-2010) (cinacalcet) | Studies (26,26,26,27,27,27-hexafluoro-1,25-dihydroxyvitamin d3) | Trials (26,26,26,27,27,27-hexafluoro-1,25-dihydroxyvitamin d3) | Recent Studies (post-2010) (26,26,26,27,27,27-hexafluoro-1,25-dihydroxyvitamin d3) |
|---|---|---|---|---|---|
| 1,070 | 155 | 627 | 45 | 5 | 3 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akizawa, T; Fukagawa, M; Fukuhara, S; Fukuma, S; Ito, K; Matsushita, K; Tanaka, M; Yoshida, K | 1 |
1 other study(ies) available for cinacalcet and 26,26,26,27,27,27-hexafluoro-1,25-dihydroxyvitamin d3
| Article | Year |
|---|---|
Effects of Secondary Hyperparathyroidism Treatment on Improvement in Anemia: Results from the MBD-5D Study.
Topics: Aged; Anemia; Calcimimetic Agents; Calcitriol; Case-Control Studies; Cinacalcet; Diabetes Complications; Female; Follow-Up Studies; Glomerulonephritis; Hemoglobins; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Middle Aged; Odds Ratio; Parathyroid Hormone; Prospective Studies; Receptors, Calcitriol; Renal Dialysis; Treatment Outcome | 2016 |